Volitionrx Ltd

Ownership Transactions Reported by 23 Insiders

Symbol
VNRX on NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
Location
1489 West Warm Springs Road, Suite 110, Henderson, NV

Insiders trading volume in the past year

Volitionrx Ltd executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eight Corp Ltd 10%+ Owner $20.8M Jan 2, 2024
Cameron John Reynolds President and CEO, Director $1.84M +$180K +10.9% Mar 26, 2025
Martin Charles Faulkes Executive Director, Director $1.74M Jan 24, 2024
Guy Archibald Innes Director $1.61M +$301K +22.9% Mar 26, 2025
Timothy I. Still Director $851K +$50K +6.24% Dec 9, 2024
Rodney Gerard Rootsaert Secretary $658K Mar 1, 2025
Edward Futcher Director $362K Jan 24, 2024
Jacob Vincent Micallef Chief Scientific Officer $279K +$25K +9.85% Jan 29, 2025
Gaetan Michel Chief Operating Officer $265K Sep 1, 2024
Terig Hughes Chief Financial Officer $223K Mar 1, 2025
Salvatore Thomas Butera CEO - Volition Veterinary $179K Mar 1, 2025
Alan Colman Director $140K Mar 1, 2025
Gael Forterre Chief Commercial Officer $115K Mar 1, 2025
Jasmine Kway CEO - Singapore Volition $111K Mar 1, 2025
Nicholas Plummer GC - Volition Diagnostics $102K Mar 1, 2025
Ann-Louise Batchelor Group Chief Marketing Officer $90.6K Mar 1, 2025
Andrew Retter Chief Medical Officer $78.7K Mar 1, 2025
Kim Nguyen Director $66.9K Mar 1, 2025
Phillip Barnes Director $37.1K Sep 1, 2024
Mickie Henshall Director $28K Aug 15, 2024
Jason Bradley Terrell Md Chief Medical Officer $27.6K Aug 3, 2022
Richard Brudnick Director $23.2K Jan 12, 2023
Ethel Rubin Director $19.2K Mar 1, 2025

Recent Insider Transactions by Companies or Individuals for Volitionrx Ltd

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.